GDF2 and COVID-19: Finally, reduced circulating BMP9 levels, a pulmonary endothelial-protective factor, have been described in hospitalized COVID-19 patients, and this has prompted the authors of this study to propose that BMP9 could offer a novel approach to preventing increased pulmonary endothelial permeability [49].